COMPOUNDS FOR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING

Andreas Petrovic (Inventor), Stefan Spirk (Inventor), Hermann Scharfetter (Inventor), Roland Fischer (Inventor), Danuta Kruk (Inventor)

Research output: PatentResearch

Abstract

The invention relates to a contrast agent particle comprising a carrier particle having a particle size of between 5 and 200 nm and at least one quadrupolar compound comprising at least one bismuth as a quadrupolar nucleus, wherein the at least one quadrupolar compound is bound to the carrier particle via at least one linker. The invention also relates to a Magnetic Resonance Imaging contrast medium (MRI contrast medium) comprising a contrast agent particle according to the invention. Furthermore, the invention relates to the use of contrast agent particles and Magnetic Resonance Imaging media according to the invention in Quadrupole Relaxation Enhancement (QRE)-based Magnetic Resonance Imaging.

Translated title of the contributionCOMPOUNDS FOR USE AS CONTRAST AGENTS IN MAGNETIC RESONANCE IMAGING
Original languageGerman
Patent numberEP3292876
IPCA61K 49/ 18 A I
Priority date12/09/16
Publication statusPublished - 14 Mar 2018

Fingerprint

inventions
magnetic resonance
bismuth
quadrupoles
nuclei
augmentation

Cite this

NEUARTIGE VERBINDUNGEN ZUR VERWENDUNG ALS KONTRASTMITTEL IN MAGNETRESONANZBILDGEBUNG. / Petrovic, Andreas (Inventor); Spirk, Stefan (Inventor); Scharfetter, Hermann (Inventor); Fischer, Roland (Inventor); Kruk, Danuta (Inventor).

IPC No.: A61K 49/ 18 A I. Patent No.: EP3292876.

Research output: PatentResearch

@misc{be2979cc695e4571aebd5c066292586a,
title = "NEUARTIGE VERBINDUNGEN ZUR VERWENDUNG ALS KONTRASTMITTEL IN MAGNETRESONANZBILDGEBUNG",
abstract = "The invention relates to a contrast agent particle comprising a carrier particle having a particle size of between 5 and 200 nm and at least one quadrupolar compound comprising at least one bismuth as a quadrupolar nucleus, wherein the at least one quadrupolar compound is bound to the carrier particle via at least one linker. The invention also relates to a Magnetic Resonance Imaging contrast medium (MRI contrast medium) comprising a contrast agent particle according to the invention. Furthermore, the invention relates to the use of contrast agent particles and Magnetic Resonance Imaging media according to the invention in Quadrupole Relaxation Enhancement (QRE)-based Magnetic Resonance Imaging.",
author = "Andreas Petrovic and Stefan Spirk and Hermann Scharfetter and Roland Fischer and Danuta Kruk",
year = "2018",
month = "3",
day = "14",
language = "deutsch",
type = "Patent",
note = "EP3292876; A61K 49/ 18 A I",

}

TY - PAT

T1 - NEUARTIGE VERBINDUNGEN ZUR VERWENDUNG ALS KONTRASTMITTEL IN MAGNETRESONANZBILDGEBUNG

AU - Petrovic, Andreas

AU - Spirk, Stefan

AU - Scharfetter, Hermann

AU - Fischer, Roland

AU - Kruk, Danuta

PY - 2018/3/14

Y1 - 2018/3/14

N2 - The invention relates to a contrast agent particle comprising a carrier particle having a particle size of between 5 and 200 nm and at least one quadrupolar compound comprising at least one bismuth as a quadrupolar nucleus, wherein the at least one quadrupolar compound is bound to the carrier particle via at least one linker. The invention also relates to a Magnetic Resonance Imaging contrast medium (MRI contrast medium) comprising a contrast agent particle according to the invention. Furthermore, the invention relates to the use of contrast agent particles and Magnetic Resonance Imaging media according to the invention in Quadrupole Relaxation Enhancement (QRE)-based Magnetic Resonance Imaging.

AB - The invention relates to a contrast agent particle comprising a carrier particle having a particle size of between 5 and 200 nm and at least one quadrupolar compound comprising at least one bismuth as a quadrupolar nucleus, wherein the at least one quadrupolar compound is bound to the carrier particle via at least one linker. The invention also relates to a Magnetic Resonance Imaging contrast medium (MRI contrast medium) comprising a contrast agent particle according to the invention. Furthermore, the invention relates to the use of contrast agent particles and Magnetic Resonance Imaging media according to the invention in Quadrupole Relaxation Enhancement (QRE)-based Magnetic Resonance Imaging.

M3 - Patent

M1 - EP3292876

ER -